Table 1:
Clinicopathologic characteristics of Hispanic/Latino gastric cancer patients in this study. IQR: interquartile range.
| N (%) | ||
|---|---|---|
| Number of patients | 83 | |
| Sample Sequenced | ||
| Tissue | 57 (69%) | |
| Blood only | 26 (31%) | |
| Age (median, IQR, range) | 53, 45–61, 23–85 | |
| Gender | ||
| Male | 54 (65%) | |
| Female | 29 (35%) | |
| Tumor Location | ||
| Cardia | 24 (29%) | |
| Body | 30 (36%) | |
| Antrum | 24 (29%) | |
| Overlapping | 5 (6%) | |
| Clinical Stage | ||
| Stage I (T1–2N0M0) | 1 (1%) | |
| Stage II and III (T3–4N0M0, TanyN1–3M0) | 46 (55.5%) | |
| Stage IV (TanyNanyM1) | 34 (41%) | |
| Recurrent | 2 (2.5%) | |
| Differentiation | ||
| Well | 1 (1%) | |
| Moderate | 18 (22%) | |
| Moderate/Poor | 1 (1%) | |
| Poor | 57 (69%) | |
| Unknown | 6 (7%) | |
| Lauren Classification | ||
| Diffuse | 43 (52%) | |
| Mixed | 7 (8.5%) | |
| Intestinal | 26 (31%) | |
| Unknown | 7 (8.5%) | |
|
Helicobacter pylori Infection (by histology) | ||
| Yes | 15 (18%) | |
| No | 59 (71%) | |
| Unknown | 9 (11%) | |